The antibody contract manufacturing market at an annualized rate of 12%. {claims Roots Analysis}

2
health-fitness

Summary

With over 100 therapeutic monoclonal antibodies and antibody-based products in the market

Press Release

With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone

 

Roots Analysis has announced the addition of the “Antibody Contract Manufacturing Market, 2020-2030” report to its list of offerings.

 

Key Market Insights

 

Over 100 CMOs presently claim to offer manufacturing services for antibodies

The antibody contract manufacturing market is currently dominated by the presence of small and mid-sized companies, which represent 70% of the industry stakeholders. It is also worth highlighting that more than 55% of CMOs claim to have the capabilities to manufacture antibodies across all scales of operation (preclinical, clinical and commercial).

 

More than 90% service providers are focused on the production of monoclonal antibodies

 

For more Insightful Information – https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html

 

 

 

North America and Europe are anticipated to capture over 70% of the market share by 2030

However, the market in the Asia is anticipated to grow at a relatively faster rate. Further, presently, more than 90% of the antibodies are being developed using mammalian expression systems, and this trend is unlikely to change significantly in short to mid-term.

 

To request a sample copy of Report – https://www.rootsanalysis.com/reports/antibody-cmo-market/request-sample.html

                                                                                     

 

The report features inputs from eminent industry stakeholders, according to whom antibody therapeutics developers are increasingly outsourcing their manufacturing operations owing to complex nature of the overall process, as well as the high investments associated with setting-up in-house expertise. The report includes detailed transcripts of discussions held with the following experts:

  • Dietmar Katinger (Chief Executive Officer, Polymun Scientific)
  • David C Cunningham (Director, Corporate Development, Goodwin Biotechnology)
  • Claire Otjes (Marketing Manager, Batavia Biosciences)

 

The research covers profiles of key players that offer manufacturing services for antibodies, featuring a company overview, information on their respective service portfolios, manufacturing facilities and capabilities, and an informed future outlook.

  • AGC Biologics
  • Aldevron
  • AMRI
  • Boehringer Ingelheim BioXcellence
  • Emergent BioSolutions
  • Eurofins CDMO
  • FUJIFILM Diosynth Biotechnologies
  • KBI Biopharma
  • Lonza
  • Nitto Avecia Pharma Services
  • Novasep
  • Pierre Fabre
  • Samsung BioLogics
  • Synthon
  • Thermo Fisher Scientific

 

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]

LinkedIn – https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter – https://twitter.com/RootsAnalysis